Literature DB >> 11311217

Correlation between total homocysteine, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol in the serum of patients with myocardial infarction.

D Qujeq1, T S Omran, L Hosini.   

Abstract

OBJECTIVES: Determine the Low-density lipoprotein cholesterol (LDL-C), High-density lipoprotein cholesterol (HDL-C) and serum total homocysteine in myocardial infarction patients and control subjects. DESIGN AND METHODS: The study group consisted of 126 patients 67 male, and 59 females, aged 29-73 (mean 48.65 +/- 3.81) years. The entry criteria for the patient group was typical or atypical chest pain, unequivocal changes in the electrocardiogram. The control group consisted of 135 normal volunteers, 71 male and 64 females, age 21-63 (mean 42.73 +/- 5.79) years. Measurement of serum total homocysteine was performed using gas chromatography. Measurement of Low-density lipoprotein cholesterol, and High-density lipoprotein cholesterol were performed using spectrophotometer.
RESULTS: Patients with myocardial infarction were found to have higher serum total homocysteine levels than controls, (P < 0.05). Serum total homocysteine levels were significantly correlated with low-density lipoprotein cholesterol and high-density lipoprotein cholesterol. There was a negative correlation between total homocysteine and HDL-C levels (P < 0.05, r = -0.93). There was a positive correlation between total homocysteine and LDL-C levels (P < 0.05, r = 0.98).
CONCLUSIONS: The above mentioned findings suggest the potential usefulness of LDL-C, HDL-C and serum total homocysteine as prognostic markers in myocardial infarction patients. These findings should influence future studies on the etiology and pathogenesis of myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11311217     DOI: 10.1016/s0009-9120(01)00187-4

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  16 in total

1.  Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis.

Authors:  Meng Lee; Keun-Sik Hong; Shen-Chih Chang; Jeffrey L Saver
Journal:  Stroke       Date:  2010-04-22       Impact factor: 7.914

2.  Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance.

Authors:  Dan Liao; Hongmei Tan; Rutai Hui; Zhaohui Li; Xiaohua Jiang; John Gaubatz; Fan Yang; William Durante; Lawrence Chan; Andrew I Schafer; Henry J Pownall; Xiaofeng Yang; Hong Wang
Journal:  Circ Res       Date:  2006-08-24       Impact factor: 17.367

3.  Lipid, Oxidative and Inflammatory Profile and Alterations in the Enzymes Paraoxonase and Butyrylcholinesterase in Plasma of Patients with Homocystinuria Due CBS Deficiency: The Vitamin B12 and Folic Acid Importance.

Authors:  Camila Simioni Vanzin; Caroline Paula Mescka; Bruna Donida; Tatiane Grazieli Hammerschimidt; Graziela S Ribas; Janaína Kolling; Emilene B Scherer; Laura Vilarinho; Célia Nogueira; Adriana Simon Coitinho; Moacir Wajner; Angela T S Wyse; Carmen Regla Vargas
Journal:  Cell Mol Neurobiol       Date:  2015-03-25       Impact factor: 5.046

4.  The effect of vitamin B6 and folate supplements on plasma homocysteine and serum lipids levels in patients on regular hemodialysis.

Authors:  S Ziakka; G Rammos; S Kountouris; C Doulgerakis; P Karakasis; C Kourvelou; N Papagalanis
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

5.  The association of MTHFR C677T gene variants and lipid profiles or body mass index in patients with diabetic and nondiabetic coronary heart disease.

Authors:  Ozlem Kucukhuseyin; Ozlem Kurnaz; A Basak Akadam-Teker; Turgay Isbir; Zehra Bugra; Oguz Ozturk; Hulya Yilmaz-Aydogan
Journal:  J Clin Lab Anal       Date:  2013-11       Impact factor: 2.352

6.  DNA methylation status of the methylenetetrahydrofolate reductase gene promoter in peripheral blood of end-stage renal disease patients.

Authors:  Maivel Ghattas; Fatma El-Shaarawy; Noha Mesbah; Dina Abo-Elmatty
Journal:  Mol Biol Rep       Date:  2013-12-21       Impact factor: 2.316

7.  B-vitamins, homocysteine and gene polymorphism in adults with fasting or post-methionine loading hyperhomocysteinemia.

Authors:  Chien-Hsiung Cheng; Yi-Chia Huang; Feng-Pan Chen; Ming-Chih Chou; Tsung-Po Tsai
Journal:  Eur J Nutr       Date:  2008-10-31       Impact factor: 5.614

Review 8.  Isolated low high density lipoprotein-cholesterol (HDL-C): implications of global risk reduction. Case report and systematic scientific review.

Authors:  Melvin R Hayden; Suresh C Tyagi
Journal:  Cardiovasc Diabetol       Date:  2005-01-04       Impact factor: 9.951

9.  Homocystein as a risk factor for developing complications in chronic renal failure.

Authors:  Biljana Jakovljevic; Branislav Gasic; Pedja Kovacevic; Zvezdana Rajkovaca; Tijana Kovacevic
Journal:  Mater Sociomed       Date:  2015-04-05

10.  Plasma folate, but not homocysteine, is associated with Apolipoprotein A1 levels in a non-fortified population.

Authors:  Elisabet Söderström; Mats Eliasson; Owe Johnson; Göran Hallmans; Lars Weinehall; Jan-Håkan Jansson; Johan Hultdin
Journal:  Lipids Health Dis       Date:  2013-05-22       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.